BrainChip Holdings Ltd (BRN.AX)
-
BrainChip Inc. and NaNose Medical Successfully Detect COVID-19 in Exhaled Breath with Fast High-Accuracy Results
Det er helt utroligt hvad der er af mugligheder her, det er jo ikke kun Covid-19 den kan sniffe sig frem til men et hel række sygdomme og mere præcist end (RT-PCR) test.
https://brainchipinc.com/brainchip-nanose-successfully-detect-covid19/
-
The features that attracted NaNose Medical to use the BrainChip processor were low power, high performance, low cost and can function as a complete solution removing the need for external CPUs, memory or accelerator chips. Elements that are essential to the further development of this technology into a cost-effective, handheld diagnostic system that is easily deployable worldwide. This innovation points the way to other possible pairings of AI with dissimilar technologies to enter a whole host of different applications and markets where the selection of the right elements and identification of the right use-cases opens up many new areas of improvement through better sensing, testing and analysis of data.
Paa vedhæftningen kan man se hvilke sygdomme der foreløbig kan diagnoses med deres apparat, det er jo helt utroligt!
-
Is Neuromorphic Computing Using Edge The Future Of AI?
Neuromorphic processors aim to provide vastly more power-efficient operations by modelling the core workings of the brain.
Her er BrainChip også nævnt.
https://datatechvibe.com/ai/is-neuromorphic-computing-using-edge-the-future-of-ai/
-
March 19, 2021
COVID-19 Breathalyzer Technology on Road to CommercializationTechnion Professor Hossam Haick has taken a big step forward to commercialize his acclaimed artificial nose technology into a breath test for COVID-19.
His company, NaNose Medical, is partnering with California-based BrainChip Holdings Ltd., which makes artificial intelligence chips, to create an easy-to-use portable device for physicians called DiaNose that could prove more accurate than existing PCR tests.
Prof. Haick's NaNose nanosensor technology can identify signature scents of COVID-19 and other diseases in a person's exhaled breath. In developing the COVID test, NaNose Medical collected 130 breath samples from patients with and without the virus. That data was then used to train BrainChip's Akido neural processor to analyze the samples to detect COVID-19. A study from China in June 2020 suggested that breath analysis could be a more sensitive method for accurately detecting the virus than even the gold standard PCR tests.
Moreover, their breath test does not require mucus or saliva samples, making it less intrusive for patients and safer for physicians and lab technicians. And medical staff would not need to send the tests out for analysis, allowing patients to get results before leaving the doctor's office or test facility.
"Using the NaNose Medical artificial nose and Akido's artificial brain is a potential breakthrough in accurate, fast, inexpensive, widespread testing with the potential to control outbreaks and reduce this disease's death toll," said BrainChip co-founder and CEO Orit Marom Albeck.
Three Projects Win Health Innovation Grant
Uncover the groundbreaking research projects that emerged from Technion's initiative to address 21st-century health challenges.
American Technion Society (ats.org)
Jeg forventer at komme til at tjene mange penge med BrainChip over de kommende år.
-
Saa er der en ny frisk research report fra Pitt Street, de har stadig et kurs mål på 1.5 Aus$, hvilket er godt 60% over nuværende kurs.
-
BrainChip selected by U.S. Air Force Research Laboratory to develop AI-based radar
2022-03-23 16:27 HKTDen gode nyhed kom efter Australien market lukketid, den er steget meget på Frankfurt i dag
-
5 april 2022:
BrainChip, SiFive partner to bring AI and ML to edge computing -
April 13th, 2022 ' 17:50 CEST
Infineon, BrainChip, Nvidia - Chip market facing the next wavePrisen på Brainchip er lav nu, så hvis man vil med på rejsen er det værd at overveje at købe ind nu.
Jeg har selv et godt stykker over 100.000 aktier og jeg overvejer om jeg skal købe flere da jeg finder investeringen meget meget sikker og ikke så nerve pirrende og risikabel som Biotech som jo bekendt er knald eller fald, mest fald.
Der er overhovet ingen tvivl om at dette firma kommer til at tjene rigtigt mange penge over de næste år efter min beskedne mening.
Infineon, BrainChip, Nvidia - Chip market facing the next wave
Due to current events in connection with the Ukraine conflict and the announced sanctions against Russia, certain everyday goods are becoming scarce. Currently, consumers face empty supermarket shelves for sunflower oil, for example. It seems almost forgotten that there is also still a shortage of semiconductors. This crisis could worsen because of the war. One reason is that the noble gas neon, which is necessary for chip production, could run out. Intel CEO Gelsinger expects the chip shortage to last into 2023.
news|financial (news.financial)
-
20/04-22
Endnu en partner til BrainChip!
Det går hurtigt med få nye partnere men vær klar over at ikke alle partnere vil tillade BC at fortælle offentligheden om et samarbejde så der er helt sikkert mange flere end vi ved om.
Jeg regner med at vi for alvor vil se fremgang i indtjening i 2023 når de forskellige partnerne for alvor begynder at lave/sælge produkter med BrainChip Alkida chips indbygget og BC vil indkassere royalties for deres IP (licens om man vil).
BrainChip and NVISO Partner on Human Behavioral Analytics in Automotive and Edge AI Devices
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind